pressurecash

259 results found.

Top Stocks matching your search for "pressure cash"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 6, 2023

Outstanding pressure today bull!!

Dec, 8, 2022

$HKD L2 buying pressure is insane -> PR drops a... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
INM

InMed Pharmaceuticals Inc

-31.19%

$2.02 - $1.39

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 24, 2023

Despite the many economic pressures affecting busi... See more

Jan, 12, 2023

$INM looks like they are still borrowing Short sha... See more

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 6, 2023

Outstanding pressure today bull!!

Dec, 8, 2022

$HKD L2 buying pressure is insane -> PR drops anytime will go parabolic 💯

Dec, 7, 2022

$HKD L2 buying pressure is insane and big breakout is inevitable!

Dec, 4, 2022

$HKD rally on L2 buying pressure will come soon!

Nov, 8, 2022

Easy 10x with buying pressure.

Oct, 13, 2022

BUY it up and keep the pressure on these Fuks

INM

InMed Pharmaceuticals Inc

-31.19%

$2.02 - $1.39

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 24, 2023

Despite the many economic pressures affecting businesses on a global scale, including challenging capital markets, particularly in biotech, InMed was able to advance its programs and achieve a number of key milestones.

Jan, 12, 2023

$INM looks like they are still borrowing Short shares … smh … just keep the buying pressure on them!